Literature DB >> 16924031

Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women.

Paula Alhola1, Päivi Polo-Kantola, Risto Erkkola, Raija Portin.   

Abstract

The authors evaluated the effect of long-term hormone therapy (HT) on cognition in 60 postmenopausal women (aged 53 to 72 years) in a single-blind, 6-year follow-up study. The subjects were divided into three groups: non-HT users, continuous HT users, and irregular HT users. Measures of verbal and visuomotor skills, verbal and visual memory, and attention were used. All women had well-maintained cognitive performance. Long-term HT did not affect cognition, either for better or for worse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924031     DOI: 10.1212/01.wnl.0000230135.10179.86

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 2.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

3.  Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.

Authors:  Juha Puustinen; Ritva Lähteenmäki; Päivi Polo-Kantola; Paula Salo; Tero Vahlberg; Alan Lyles; Pertti J Neuvonen; Markku Partinen; Ismo Räihä; Sirkka-Liisa Kivelä
Journal:  Eur J Clin Pharmacol       Date:  2013-12-12       Impact factor: 2.953

4.  Cognitive response to estradiol in postmenopausal women is modified by high cortisol.

Authors:  Laura D Baker; Sanjay Asthana; Brenna A Cholerton; Charles W Wilkinson; Stephen R Plymate; Pattie S Green; George R Merriam; Mark A Fishel; G Stennis Watson; Monique M Cherrier; Monica L Kletke; Pankaj D Mehta; Suzanne Craft
Journal:  Neurobiol Aging       Date:  2011-08-19       Impact factor: 4.673

5.  Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women.

Authors:  C Neill Epperson; Brian Pittman; Kathryn A Czarkowski; Jeanette Bradley; Donald M Quinlan; Thomas E Brown
Journal:  Menopause       Date:  2011-05       Impact factor: 2.953

6.  Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone.

Authors:  Mary Lou Voytko; Rhonda Murray; Casey J Higgs
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.